Latest News for: ip australia
Edit
Herald & Review - Decatur
11 Feb 2026
Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with ...
Herald & Review - Decatur
11 Feb 2026
Patent Covers Acclaim-3 Clinical Trial Combining REQORSA Gene Therapy with Genentech, Inc.'s Tecentriq® ... .
Edit
Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
PR Newswire 10 Feb 2026
GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that IP Australia, the Australian government agency ...
- 1